CO - Global Cord Blood Corporation

NYSE -> Healthcare -> Diagnostics & Research

Central, Hong Kong

Type: Equity

Current assets
(in millions $)	30 Mar 2022	30 Dec 2021	29 Sep 2021	30 Jul 2021
Cash	$6660.98	$6505.01	$6390.63	$966.05
Short term investments
Net receivables	$161.3	$154.07	$144.67	$20.97
Inventory	$45.88	$47.39	$33.82	$5.72
Total current assets	$6935	$6782.2	$6648.46	$1003.11
Long term investments	$282.3	$296.86	$298.1	$311
Property, plant & equipment	$476.69	$483.66	$488.4	$75.71
Goodwill & intangible assets
Total noncurrent assets				$250.64
Total investments
Total assets	$8534.52	$8397.73	$8258.26	$1253.75
Current liabilities
Accounts payable	$8.33	$11.67	$13.44	$2.15
Deferred revenue				$70.26
Short long term debt
Total current liabilities	$646.56	$636.49	$650.78	$99.83
Long term debt
Total noncurrent liabilities				$453.01
Total debt
Total liabilities	$3649.55	$3610.13	$3604.85	$552.84
Shareholders' equity
Retained earnings	$2887.25	$2782.54	$2648.34	$390.7
Other shareholder equity	-$106.79	-$106.72	-$105.35	-$15.3
Total shareholder equity	$4879.32	$4774.67	$4641.84	$4516.33

Current assets
(in millions $)	30 Mar 2022	30 Mar 2021	30 Mar 2020	30 Mar 2019
Cash	$6660.98	$6075.8	$5473.37	$4997.86
Short term investments
Net receivables	$161.3	$135.07	$110.28	$107.71
Inventory	$45.88	$44.26	$43.76	$27.61
Total current assets	$6935	$6298.14	$5666.17	$5147.93
Long term investments	$282.3	$307.04	$290.44	$296.49
Property, plant & equipment	$476.69	$503.69	$527.23	$545.34
Goodwill & intangible assets
Total noncurrent assets		$245.46	$219.42	$209.06
Total investments
Total assets	$8534.52	$7906.33	$7219.85	$6550.95
Current liabilities
Accounts payable	$8.33	$9.48	$19.99	$33.57
Deferred revenue		$68.59	$56.88	$68.84
Short long term debt
Total current liabilities	$646.56	$626.47	$570.78	$595.64
Long term debt
Total noncurrent liabilities		$441.31	$389.87	$377.36
Total debt
Total liabilities	$3649.55	$3517.88	$3331.36	$3128.19
Shareholders' equity
Retained earnings	$2887.25	$2386.19	$1877.94	$1407.22
Other shareholder equity	-$106.79	-$103.18	-$94.66	-$88.74
Total shareholder equity	$4879.32	$4381.86	$3882.13	$3417.34

Revenue
(in millions $)	30 Oct 2022	30 Jul 2022	30 Mar 2022	30 Dec 2021
Total revenue			$297.21	$317.2
Cost of revenue			$41.98	$47.28
Gross Profit			$255.23	$269.92
Operating activities
Research & development			$4.78	$6.84
Selling, general & administrative			$108.31	$113.36
Total operating expenses			$155.07	$167.48
Operating income			$142.14	$149.72
Income from continuing operations
EBIT			$142.14	$149.72
Income tax expense			$33.27	$23.57
Interest expense
Net income
Net income			$104.72	$134.19
Income (for common shares)			$104.72	$134.19

Revenue
(in millions $)	30 Mar 2022	30 Mar 2021	30 Mar 2020	30 Mar 2019
Total revenue	$1243.26	$1159.64	$1221.46	$986.75
Cost of revenue	$183.31	$178.95	$189.13	$186.03
Gross Profit	$1059.95	$980.69	$1032.33	$800.73
Operating activities
Research & development	$22.3	$23.77	$21.11	$14.69
Selling, general & administrative	$428.79	$412.05	$452.19	$404.38
Total operating expenses	$634.39	$614.77	$662.43	$605.1
Operating income	$608.87	$544.87	$559.03	$381.66
Income from continuing operations
EBIT	$608.87	$544.87	$559.03	$381.66
Income tax expense	$118.35	$94.55	$101.08	$61.26
Interest expense
Net income
Net income	$501.06	$508.25	$470.72	$291.12
Income (for common shares)	$501.06	$508.25	$470.72	$291.12

Operating activities
(in millions $)	30 Mar 2022	30 Dec 2021	29 Sep 2021	30 Jul 2021
Net income	$104.72	$134.19	$125.74
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations
Investing activities
Capital expenditures
Investments
Total cash flows from investing
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Total cash flows from financing
Effect of exchange rate
Change in cash and equivalents

Operating activities
(in millions $)	30 Mar 2022	30 Mar 2021	30 Mar 2020	30 Mar 2019
Net income	$501.06	$508.25	$470.72	$291.12
Depreciation		$49.09	$49.45	$52.37
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations		$630.71	$624	$792.12
Investing activities
Capital expenditures		-$20.89	-$24.24	-$30.69
Investments
Total cash flows from investing		-$20.11	-$146.06	-$30.21
Financing activities
Dividends paid		-$0.93	-$0.57	-$18.17
Sale and purchase of stock
Net borrowings
Total cash flows from financing		-$6.07	-$4.04	-$21.19
Effect of exchange rate		-$2.1	$1.61	$6.54
Change in cash and equivalents		$602.42	$475.51	$747.25

Companies Knew the Dangers of PFAS 'Forever Chemicals'—and Kept Them Secret

Time via Yahoo News 2 Jun 2023

MedTech Stocks' Q1 Earnings Due on Apr 26: MMSI, CNMD & More

Zacks via Yahoo Finance 25 Apr 2023

Abbott's (ABT) New Launch to Boost Blood Donation Experience

Zacks via Yahoo Finance 9 Jan 2023

Here's Why You Should Retain Cooper Companies (COO) Stock Now

Zacks via Yahoo Finance 16 Nov 2022

Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day...

Investing.com 23 Sep 2022

Here's Why You Should Retain Cooper Companies (COO) Stock Now

Zacks via Yahoo Finance 18 Aug 2022

Lions Gate Entertainment Corporation Class A (LGF.A) Q1 2023 Earnings Call Transcript

Motley Fool 5 Aug 2022

Is Invitae Stock a Buy Under $5?

Entrpreneur 4 May 2022

66 Biggest Movers From Yesterday

Benzinga 3 May 2022

31 Stocks Moving In Monday's Mid-Day Session By Benzinga

Investing.com 2 May 2022